By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Charleston Laboratories, Inc. 

65 Gasden Street
Suite 201
Charleston  South Carolina  29401  U.S.A.
Phone: 843-577-2626 Fax: 843-628-1061


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
Daiichi Sankyo, Inc. (4568.t) Wagers Up To $650 Million On Charleston Laboratories, Inc.'s Pain And Opioid-Induced Nausea And Vomiting Drug 8/7/2014 8:43:55 AM
Charleston Laboratories, Inc. Bolsters Senior Management Team 5/8/2014 7:19:10 AM
Charleston Laboratories, Inc. Announces Publication Of Abstract for CL-108 Phase 3 Study At APS 2014 5/2/2014 11:45:21 AM
Strong Efficacy Data Prompt Charleston Laboratories, Inc. to Halt Phase 3 Pain Study of CL-108 10/29/2013 7:07:50 AM
Charleston Laboratories, Inc. Announces Research Collaboration With Stanford University 10/9/2013 10:12:04 AM
Charleston Laboratories, Inc. Announces Successful Completion of Pre-IND Meeting on New Migraine Treatment CL-H1T 7/23/2013 10:09:31 AM
FDA Grants Charleston Laboratories, Inc. Request for Pre-IND Meeting on New Migraine Treatment 4/16/2013 10:56:42 AM
Charleston Laboratories, Inc. Begins Enrollment for CL-108 Phase 3 Clinical Trial 1/28/2013 10:35:55 AM
Charleston Laboratories, Inc. Awarded a Qualifying Therapeutic Discovery Project (QTDP) Grant Under the U.S. Patient Protection and Affordable Care Act of 2010 11/3/2010 7:10:42 AM
Charleston Laboratories, Inc. Completes Exploratory Bioequivalence Study of CL-108 5/18/2009 2:40:36 PM
12
//-->